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INTRODUCTION
1INTRODUCTION
Varicose veins are a common problem and one of the most
prevalent medical disorders affecting approximately 10 to 40% of the
general population. The lower limb venous system is classified into the
superficial system, the perforator and communicating systems and the
deep system. In most of the cases the varicose veins of lower limbs are
due to superficial venous incompetence which results in the
development of truncal varicosities. This occurs in 32% of women and
40% of men (Edinburg Vein Study). Varicose veins are classified as
primary and secondary varicose veins. About 60 to 70% of primary
varicose vein develop due to Sapheno Femoral Junction (SFJ)
incompetence and Great Saphenous Vein (GSV) reflux while in about
10% it is due to Sapheno Popliteal Junction (SPJ) and Small Saphenous
Vein (SSV) incompetence.
Asymptomatic superficial venous reflux occur in 39% of cases
and present as cosmetic problem alone, but in the rest of the cases it
presents with symptoms such as restless leg, discomfort, ache,
heaviness, pain, swelling, hyper pigmentation and eczematous skin
changes, ulcers, bleeding, superficial thrombophlebitis and disability
such as talipes equino varus.
2Treatment of varicose veins is for three main reasons. In the first
instance, treatment is to prevent occurrence of complications, such as
bleeding, edema, eczema, lipodermatosclerosis and leg ulcers. Leg
ulcer treatment is intense and sincere perseverance and endurance is
required from both the patient and physician side. It is very expensive
owing to its chronicity the duration of treatment required is prolonged.
Leg ulcers have a major impact on patients’ social life as reflected by
the health related quality of life (HRQOL). Secondly, varicose vein
treatment also relieves symptoms caused by varicose veins, such as
heaviness, tired legs and cramps. Cosmetic reasons are the third reason
for treatment.
Treatment begins with the abolition of venous reflux and thereby
reducing ambulatory venous hypertension, which is the key point for
successful treatment. This can be achieved by surgical ablation or by
endovenous ablation of saphenous vein reflux.
Surgical ablation in the form of high ligation of SFJ and
stripping of GSV is more than a century old and is considered the gold
standard. Lot of innovations in the treatment of varicose veins has
developed with the aim of reducing the morbidities associated with the
standard surgical procedure. Among them are the endovenous ablations
with radio frequency ablation, laser ablation and foam sclerotherapy.
3Though the endovenous ablation techniques are a decade old,
there are only a few studies in the international literatures comparing
these procedures with that of the conventional surgical procedure. Also
the national literatures have reported only the case series in the
individual endovenous procedures and no comparative study appears to
be available so far.
This study compares the outcome of the management of truncal
varicose veins in a series of patients presenting to our tertiary care
referral centre over a period of one year. The traditional conventional
open surgical technique is compared with that of the latest and the
newest minimal access endovenous ablative procedures. This
comparative study is made feasible because our centre, the Govt.
Stanley Medical College and Hospital, Chennai is the first in the
government set up to have these endovenous ablation gadgets and
provide these minimally invasive endovenous ablations.
AIMS &
OBJECTIVES
4AIM OF THE STUDY
The purpose of this study was to compare the pre procedural,
intra procedural and post procedural assessments and thereby evaluate
the efficacy of treatment with endovenous technique in comparison
with open technique for abolishing primary superficial venous
incompetence and thereby bringing about clinical improvement.
MATERIALS &
METHODS
5     MATERIAL AND METHODS
STUDY DESIGN: The study was designed as a Prospective study
comparing procedure related complications and patient recuperation
between those undergoing conventional high flush ligation of SFJ
(Trendelenburg procedure) and GSV stripping (HL/S) with those
undergoing GSV obliteration with endovenous thermal ablation
procedure (i.e.) Radio Frequency Ablation (RFA) or LASER ablation
(EVLA).
DURATION: January 2012 to January 2014
SETTING: The patients with varicose vein attending the Vascular
Surgery OPD of Govt. Stanley Medical College and Hospital, Chennai
were enrolled for study. All symptomatic patients were admitted and
evaluated with proper clinical history, thorough clinical examination
and duplex evaluation. Based on inclusion and exclusion criteria
patients were selected and treated accordingly.
The study was approved by the Ethics Committee of the institution.
6INCLUSION CRITERIA:
1) Patients in the age group between 20 to 80 years
2) Both males and females were included
3) Patients with varicosity of GSV with grade II reflux and above of
the sapheno femoral junction
4) Patients with venous ulcer with GSV varicosity (i.e) CEAP
classification C2 to C6 (i.e) C2-6 EP AS PR.
EXCLUSION CRITERIA:
1) Patients with secondary varicose veins due to previous DVT.
2) Patients with recurrent varicose veins
3) Patients with perforator incompetence alone
4) Patients with segmental reflux
5) Female patients with pregnancy
6) Congenital anomalies (E.g.) Klippel Trenaunay Syndrome (KTS)
7) Patients with GSV diameter greater than 1.2cm
8) Patients with ABI less than o.9
79) Patients with general co- morbid conditions like CCF, CRF, open
PTB and those mentally unfit to comprehend and give consent to
the course of treatment.
INVESTIGATION PROTOCOL:
 Rutherford et al described the Venous Clinical Severity Score (VCSS).
There are 10 descriptors namely pain, varicose vein, venous edema,
skin pigmentation, inflammation, induration, ulcer number, ulcer
duration, ulcer size and compressive treatment each of which is ranked
as 0 (absent), 1(mild), 2(moderate), or 3(severe). The  possible scores
are in the range of  0 to 30. The signs and symptoms were recorded
using this VCSS score. Also the CEAP classification was applied for
varicose vein description which includes the clinical, etiological,
anatomical and pathological nature of the disease. Duplex examination
was used to record duration of SFJ reflux and diameter of GSV 3 cm
below SFJ, at mid thigh and just below knee. Duplex examination was
also done to rule out deep venous thrombosis and deep vein reflux.
Also base line investigations were performed to identify the risk factors
and get them fit for surgery.
8
9TREATMENT:
 The three procedures in this study were done under regional
anesthesia.
The surgical procedure of High ligation (Trendelenburg
procedure) and GSV stripping was performed through a groin skin
crease incision of 4 to 6 cm, with flush ligation of SFJ and division of
GSV and all its tributaries near the saphenofemoral junction. The exit
of the stripper was at the below knee level or at the ankle if the
varicosity extended to the lower leg. The stripper was retrieved through
the groin wound with simultaneous application of elastic compression
bandage.
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In the other arm which included the RFA and EVLT, procedures
were performed under duplex guidance. The GSV was accessed by
percutaneous puncture with the 7Fr puncture kit or by means of a small
cut down at just below knee or in the upper calf. The catheter or the
fiber tip was placed 2 cm distal to the SFJ or just distal to the
superficial epigastric vein. Tumescent anesthesia, approximately 250-
300ml per treatment, was administered peri venously in the saphenous
canal under USG guidance.
 Radio frequency ablation (segmental ablation) was performed
using VNUS CLOSURE FAST system. The EVLA procedure was
performed using 1470nm diode laser (BIOLITEC) using continuous
mode with 11 to 12W of energy and pull back of 80J/cm. Both RFA
and EVLA were performed in limb elevated position.
 In both the groups the stab avulsion technique was used to treat
the leg perforators and branch varicosities.
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At the end of the procedure, the leg was wrapped with sterile absorbent
bandages and elastic compression bandages, i.e. elastocrepe bandages
(6in) was applied. After the first follow up, i.e. after 72 hours, patients
were advised to wear class II compression stockings for the next 12
weeks.
12
ASSESSMENTS:
Post operative follow up was done within 72 hours, 1 month, and 6
month and at 1 year. Each visit included clinical examination, duplex
ultra sound examination and documentation of CEAP staging and
VCSS.
In the RFA and EVLA group, the criteria for technical success was
considered as obliterated great saphenous vein with lack of flow and
absence of saphenous vein was considered as success in HL/S group.
Treatment failure or recanalization of great saphenous vein was defined
as any open part of the treated vein segment more than 5 cm length.
The complication was regarded as minor if no separate treatment was
required and major if they required additional treatment or prolongation
of hospital stay or led to permanent adverse event. The post operative
pain was analyzed using Visual Analogue Scale from 0 to 10 and
analgesics prescribed accordingly.
REVIEW OF
LITERATURE
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 REVIEW OF LITERATURE
TREATMENT OF VARICOSE VEINS
Chronic venous disease in a spectrum of anatomical and physiological
abnormalities of lower limb veins that is associated with signs and
symptoms. The treatment of varicose veins by surgery is aimed at
removing the unsightly branch veins. Surgical treatment helps in
removing the symptoms of chronic venous disease by reducing or
eliminating ambulatory venous hypertension. Non-invasive
investigation especially the duplex ultrasound helps to identify the
venous system involved, the duration reflux and the status of the deep
system and treatment needs to be individualized for each patient based
on these results. Depending on the nature of underlying
pathophysiology, the elimination of the varicosities can be achieved by
either or a combination of the following modes of treatment:
I)  Axial superficial venous reflux ablation
1) Surgical excision of saphenous vein reflux
2) Endovenous ablation of saphenous vein reflux
    a) Thermal ablation - radiofrequency or laser therapy
    b)Chemical ablation - Foam sclerotherapy
14
II) Varicose veins removal
1) Ambulatory surgical phlebectomy
ABLATION OF AXIAL SUPERFICIAL REFLUX
Axial reflux or gravitational reflux in the great saphenous vein (GSV)
or small saphenous vein (SSV) is called the Truncal varicosities.
Ablation of these varicosities is indicated in patients in whom reflux at
the SFJ or SPJ has been identified on duplex ultrasound. Reflux at
saphenofemoral junction occurs in 70% of patients with varicose veins.
Atypical reflux at other sites or varicosities without gravitational reflux
is found in the remaining 30% of the patients.
SURGICAL ABLATION OF SAPHENOUS VEIN REFLUX
The “gold standard” in the treatment of varicose veins is High ligation
at SFJ of the great saphenous vein with its stripping and has been
practiced widely.  The recent minimally invasive procedures have been
compared with this time tested procedure. In the current-day practice
stripping of the varicose saphenous vein is largely confined to the thigh
because this eliminates the axial reflux, which usually extends only to
the knee; thigh perforators are thus disconnected; also this reduces the
incidence of saphenous nerve injury associated with stripping of the
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below-knee segment of GSV. The perforators in the below knee
segment of saphenous vein are not connected directly to the GSV,
instead they usually drain into the posterior arch vein of Leonardo, so
actually there is no real advantage in stripping the vein up to the ankle.
Stripping can be extended to the ankle, in situations where there is
gross dilatation of the below-knee segment of the vein with reflux, as
demonstrated on duplex ultrasound, usually with the less traumatic
inversion technique. Many modifications has occurred in the methods
by which the stripping of the GSV is performed like invagination
stripping (perforate - invaginate technique, PIN), cryo stripping and to
minimize the incidence of haemorrhage, bruising, parasthesia and pain,
the use of tumescent anaesthesia with lignocaine and epinephrine in the
saphenous canal has come into vogue.
ENDOVENOUS THERMAL ABLATION OF SAPHENOUS
VENOUS REFLUX
Mechanism of action
Obliteration of the GSV by endovenous method involves thermal
damage of the vein wall. This results in destruction of the intima by a
process of selective photothermolysis and denaturation of collagen
present in the media. Eventually over time this leads to aseptic fibrotic
occlusion of the vein.
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Currently there are two widely applied methods available for
performing endovenous ablation and they are radiofrequency ablation
(RFA) and endovenous laser treatment (EVLT).  Continuous and
pulsed modes are made available for the laser system in the market by
various manufacturers and available in various frequencies as well.
 Vein wall damage is brought by Radiofrequency-induced
resistive heating and is controlled by the vein wall temperature and the
impedance feedback. Upto a depth of 1 mm, direct heating of the vein
wall occurs at the site of contact with the catheter, and by conduction,
the deeper vein wall heating occurs.
Small profile fibres are available for the laser treatment. Two
mechanism is postulated for laser-induced thermal damage. Firstly by
indirect heating damage of the vein wall is caused. Intravascular steam-
bubble is generated by the laser probe, which heats to a temperature of
1000° C, and this result in thrombotic occlusion of the vein. The
second mechanism involves a more direct heating of an empty vein,
possibly through a thin film of blood, resulting in indirect damage to
the vein wall. In the clinical setting, a combination of the two
mechanisms may probably be responsible for the efficacy of EVLT.
The lasers probes that are available at present include haemoglobin-
specific laser wavelengths (810, 940, and 980 nm) and water-specific
laser wavelengths (1320, 1319 nm and 1470nm), and their mode of
17
action is of debatable differences. For the homogeneous distribution of
the thermal damage throughout the inner vein wall, the intra vascular
blood is responsible.
LONG AND SHORT TERM RESULTS OF SUPERFICIAL REFLUX
ABLATION
The Short term results
The most accepted surgical method of ablation of superficial
reflux is stripping of the great saphenous vein up to the level of the
knee. This is combined with high ligation and disconnection of all
tributaries in the groin. Inversion stripping is less traumatic than
conventional stripping. It is shown to be associated with minimal blood
loss and decreased incidence of saphenous neuralgia, which is
confirmed in a recent randomized, controlled trial13. Compared to
stripping of the GSV, recurrent varicose veins is associated more
commonly with high ligation alone, because this operation fails to
eliminate the axial reflux13. Also as the connecting thigh perforators
feed the saphenous vein, the saphenous vein remains patent entirely or
partly.
In comparison to conventional stripping, two recent prospective,
randomized trials evaluating the advantages of cryo stripping with
conventional stripping demonstrated a shorter operative time and fewer
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bruising but similar postoperative pain, mobility, complications, and
improvement in quality of life measurement that was done
objectively13. After the advent of endovenous ablation techniques, most
of the recent studies have started to concentrate on comparing these
endovenous techniques with the traditional high ligation and stripping.
With the minimally invasive endovenous procedures most of the
practioners have observed better patient acceptance and experienced
decreased discomfort in the performance of procedures.
 Clinically the benefits of RFA over stripping has been shown in
four separate randomized clinical studies comparing this technique with
conventional stripping8,9,26,28,27,21. One among them is the EVOLVeS
study. It was a prospective, multicenter, randomized study that included
85 patients (86 limbs) randomized to radio frequency ablation versus
SFJ ligation and stripping. Closure resulted in initial occlusion rate of
91%, earlier return to work, less postoperative pain, and better early
quality-of-life scores8,9. Complication rates were similar in both the
RFA and conventional stripping groups, but the average post operative
pain was found to be significantly less severe in the radio frequency
obliteration group. Absence from work was also shorter and physical
function was restored faster than in the stripping group, resulting to be
potentially cost effective factor for the society26. With increasing
experience, the clinical outcome of RFA was further evaluated
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objectively and a significant improvement in the venous severity score
was observed21.
Like wise, the early success of ablation of the refluxing vein has
been reported as 90% to 98% of patients with EVLA13,30. Large, single-
centre experiences with EVLA have demonstrated early occlusion rates
of 97% to 98% and showed occlusion rates in 93% of limbs at 3
years30. In an international registry of 5262 patients, 96% successful
occlusion was reported by Kabnick following GSV ablation with the
980-nm laser. Also a similar efficacy in ablating the GSV is reported
with other wavelengths12,30. There are evidences that shows that the
water specific laser wavelengths (1320 and 1319 nm) result in less
postoperative discomfort; also there are no definite evidence that
supports the use of one laser wavelength over another12,25. In addition
following laser ablation, a statistically significant improvement in the
CEAP classification has been documented. In the only prospective,
randomized trial that compared EVLT with stripping which was
performed under tumescent anaesthesia in 121 patients, Rasmussen et
al. reported higher postoperative pain scores in the surgical group.
Anyhow there was no significant difference in analgesics consumed,
time to return to normal activity, or to work. In early post procedure
period there was detoriation of all quality of life measure scores but by
3 months in both groups a significant improvement was noted 21.
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The Long-Term Results
In spite of the initial morbidity of the procedure long lasting
relief from symptoms has been observed with the traditional surgical
treatment of varicose veins with high ligation and stripping. The
superior long-term outcome of stripping over high ligation alone or
sclerotherapy or a combination of the two has been confirmed in
prospective, randomized trials32,33. At a mean follow-up of 3 to 5 years,
71% to 90% of patients who have undergone stripping had functional
improvement and improved hemodynamic parameters. The SF-36 and
venous disease-specific (Aberdeen Varicose Vein Severity Score)
questionnaires34 have also demonstrated a significant improvement in
quality of life.
In a recent randomized, prospective clinical trial, the ESCHAR
(Effect of Surgery and Compression on Healing and Recurrence)
trial, evaluated stripping with or without phlebectomy and
conservative treatment in 246 patients with uncomplicated varicose
veins. At the end of 2 year follow up, it found significant improvement
in symptoms and quality of life in surgically treated patients35.
Following high ligation and stripping there is a guaranteed
abolition of the great saphenous vein, but the fate of the treated vein
following endovenous ablation yet needs to be monitored and
21
evaluated. Mid- and long-term results following RFA and EVLT has
become available recently. The duplex ultrasound has demonstrated
that, usually at 1 year and thereafter, there is complete disappearance of
the GSV or remains as minimal residual fibrous cord with no flow
detectable.
Nicolini has reported a 3-year result following RFA in 330
limbs. The total occlusion rate was 75%, 18% was partial occlusion
(less than 5 cm of open segment) , and 7% incomplete occlusion (more
than 5 cm of open segment) 36.
Merchant and Pichot in 200531 published the long-term results of
the Closure Study Group at 5 years following RFA. The multicenter,
prospective registry comprised data from more than 1200 limbs treated.
It reported occlusion rates at the end of  1, 2, and 5 years as 87.1%,
88.2%, and 87.2%, respectively.
In the same study in 185 limbs, using Duplex ultrasound one of
the following modes of anatomical failure was identified:
a)Type I failure: (nonocclusion) - (12.4%) - is the failure of veins to
occlude initially and never occluded during the follow-up.
b)Type II failure: (recanalization) - (69.7%) - refers to veins that
occluded initially , partly or completely, but recanalized at a later date.
22
c)Type III failure: (groin reflux) - (17.8%) - is the situation where the
vein trunk remained occluded, but by involvement of an accessory
vein, the reflux occurred at the groin region.
Importantly the anatomical failure did not necessarily result in
clinical failure. In most patients significant relief from symptoms of
pain, fatigue, and edema was observed. 70% to 80% of those with
anatomical failure remained asymptomatic, whereas 85% to 94% of
those with anatomical success remained asymptomatic. Identification
of Type II and type III anatomical failures is important as they are the
risk factors for recurrence of varicose vein.
A meta- analysis on Endovenous therapies of lower extremity
varicosities, conducted by a systematic review of Medline, Cochrane
Library, and Cinahl, was performed to identify studies on the
effectiveness of the four therapies up to February 2007. Of the 119
studies that were retrieved, 64 (53.8%) were eligible and assessed
12, 320  limbs. Average follow up was 32.2 months. After 3 years, the
estimated pooled success rates for stripping, foam sclerotherapy, RFA
and EVLA was 78% (70-84%), 77% (69-74%), 84% (75-90%) and
94% (87-98%) respectively. After adjusting for follow up, foam
therapy and RFA were found to be as effective as surgical therapy.
EVLA was significantly more effective when compared to stripping,
foam therapy and RFA. The study concluded that in the absence of
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large, comparative randomized clinical trials with long term follow ups,
for the treatment of lower extremity varicose veins the minimally
invasive endovenous techniques appear to be as effective as surgery.
The RELACS Study compared the effectiveness of endovenous
laser ablation and high ligation with stripping of the great saphenous
vein and gave a two year result of a randomized clinical trial. It is the
largest randomized trial that compares an endovenous approach for the
obliteration of great saphenous vein with high ligation and stripping.
The results are overall compatible with other studies, suggesting
minimal difference between EVLA and HL/S in terms of early and late
outcomes.
As a whole, regarding endovenous ablation, a review of the
literature reveals about 10 randomized trials since2005. Taken as a
whole, these trials demonstrates relatively equal efficacy of all
techniques for treatment of  axial vein reflux, with regard to post
operative pain and early return to work and normal activities, with only
a minor advantage for RFA .
A Randomized clinical trial comparing EVLA, RFA, Foam
sclerotherapy and surgical stripping for great saphenous varicose veins
with 3-year follow up  involved a total of 500 patients (580 legs). They
were randomized to one of the three endovenous treatment or high
ligation and stripping. Follow up included clinical, duplex ultrasound
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examinations, VCSS and QOL questionnaires. The study concluded
that all the four treatment modalities for axial vein reflux were
efficacious and resulted in similar improvement in VCSS and QOL.
But, more recanalization and reoperations were seen after ultra
sonogram guided foam sclera therapy.
An article on Endovenous laser therapy in the Journal of
Biophotonics reported that with latest innovative technologies, EVLA
treatment appears to be getting closer to the goal of standardizing an
effective method in the treatment of varicose veins. It proposed that
further controlled studies were required to compare the results of an
optimized endovenous laser treatment with other endo thermal methods
of treatment and the conventional open surgery of HL/S.
 From the Journal of International Angiology, The first 1000
cases of Italian Endovenous- Laser Working Group (IEWG).
Rationale , and long term outcomes for the 1999-2003 period, the
conclusion was that EVLA appears to be a good solution for all patients
with anatomic and hemodynamic patterns  instead of saphenous vein
surgery. It also concluded that endovenous ablation of great and short
saphenous vein with a 1470nm diode laser is a minimally invasive, safe
and efficient therapeutic option with high rate of success.
OBSERVATION AND
RESULTS
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OBSERVATION AND RESULTS
Patients were enrolled from January 2012 to January 2013 and the
follow up was continued till January 2014. Totally 85 cases were
enrolled out of which 46 patients underwent high ligation and stripping
and 39 patients underwent endovenous ablation. Among endovenous
ablation group 27 patients underwent radiofrequency ablation and 12
patients underwent EVLA.
TABLE 1:   TREATMENT DISTRIBUTION
                                    Procedure      Total
HL/S
                      Endovenous
           RFA           EVLA
       85
Cases             46               27               12
Total           46                             39        85
26
Of the 85 cases treated 74 patients were males and 11 patients were
females. Out of the 74 males, 39 patients underwent HL/S, 23 patients
underwent RFA, and 12 patients underwent EVLA. Among the 11
female cases, HL/S was performed in 7 patients and RFA in 4 patients.
TABLE 2: SEX INCIDENCE
        Patients       Procedure         Frequency         Percent
          Male
         HL/S  39
   74              87%         RFA  23
        EVLA  12
        Female
         HL/S  7
   11             13%         RFA  4
         EVLA  0
         Total               85           100%
HL/S -46
54%
RFA -27
32%
EVLA-12
14%
procedure
27
 SEX  INCIDENCE
TABLE 3:  AGE DISTRIBUTION
Age in yr 20-24 25-34 35-44 45-54 55-64 Total
Male 3 17 20 26 8 74
Female  0 1 7 2 1 11
Total 3 18 27 28 9 85
Table 3 shows the age group involved in this study. The age
group commonly affected both in males and females were found to be
in the range of 35 to 55 years.
0
5
10
15
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25
30
35
40
45
HL/S RFA EVLA
Male
Female
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 AGE DISTRIBUTION
85 limbs were treated in85 patients. The study did not have any
bilateral limb treated in the same sitting. Of the 85 limbs, 48 involved
left and 37 involved right lower limbs.
0
5
10
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30
20-24 25-34 35-44 45-54 55-64
Male
Female
Right=37
44%
Left=48
56%
Limb involved
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CEAP CLINICAL CLASSIFICATION:
The varicose vein patients who were symptomatic were categorized
according to CEAP classification.
TABLE 4: CEAP CLINICAL STAGING
CEAP HL/S RFA EVLA Total
C2 37 20 9 66
C2+C4a 4 1 0 5
C2+C5 4 3 0 7
C2+C6 1 3 3 7
Total 46 27 12 85
C2
78%
C2+C4a
6%
C2+C5
8%
C2+C6
8%
CEAP
30
78% (n=66) of treated patients had varicose vein alone that were
symptomatic. The symptom included restless legs, heaviness, leg ache
or edema of ankles towards evening which subsided on overnight rest.
There was no case of varicose vein operated for cosmetic reason alone.
Of the 7 patients with active ulcer one patient underwent HL/S, 3
patients underwent RFA and 3 patients underwent EVLA. The sizes of
the ulcer were between 2-4 cm averaging 3 cm. The average time taken
for ulcer to heal was 3 weeks to 3 months. There was no ulcer
recurrence in the one year period of follow up.
C2
31
C2,4a,5
C2,4a
32
All the procedures were performed under regional anesthesia. Pre
operative vein mapping was done under duplex guidance.
C2,4a,6
33
In technique comparisons, vein access of the distal extent of
saphenous vein in the leg was with cut down in all the 46 (100%)limbs
in HL/S group and in 46% (18 of 39) of limbs in endovenous group.
The other 21 limbs in endovenous group were accessed via
percutaneous puncture of GSV in the calf using 7Fr puncture kit under
ultra sound guidance.
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Procedural complications were infrequent in both the treatment
groups. Phlebectomies of superficial leg varicosities were performed by
stab avulsion technique in all patients in both the groups.
Immediate success on the day of treatment was reported in 100%
of all treated groups.
The complications and adverse events were evaluated in the peri
operative period.
TABLE 6: COMPLICATIONS AND ADVERSE EVENTS
complications
HL/S RFA EVLA P-Value
n % n % n %
HL/S
Vs
ENDO
RFA
Vs
EVLA
None 26 56.5 21 77.7 11 91.6 0.0289 0.3464
Bruising 17 36.95 1 3.7 0 0 0.0005 0.6923
Parasthesia 9 19.56 1 3.7 1 8.3 0.1312 0.6154
Burns 0  0 4 14.8 0  0 0.0110 0.2134
Wound infn. 4 8.69 1 3.7 0 0 0.4406 0.6923
Lymphocele 5 10.8 0 0 0  0 0.1052 -
Tenderness 46 100 0 0 0  0 <0.0001 -
DVT 0  0 0  0 1 8.3 0.0461 0.3077
“pulling”sensation 0  0 13 48.1 3 25
To calculate the p-Value Chi-Square test is applied.
P-value less than 0.05 was considered statistically significant.
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 COMPLICATIONS AND ADVERSE EVENTS:
The peri operative complications were observed maximally in
the HL/S group (P value=0.0001). All patients had induration and
tenderness in the groin wound from the immediate post operative
period to 2 to 3 weeks post op. The same was not a complaint in the
endovenous group as no incision was made at the groin.
Subjective assessment of pain was done using Visual Analog
Scale from 0 to 10 during the first 10 days and during periodic follow
up. The pain score was higher initially and in the subsequent 2 weeks
after HL/S compared to endovenous ablation.
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PLOT OF PAIN SCORE
The line chart clearly shows the advantage of pain score for
endovenous ablation.
However, another unique observation noted was cord like pulling
sensation or tethered sensation along the treated GSV course in the
endovascular group which was observed after 48 hours of treatment
and persisted in a few patients (n=8, 29.62%) until the third follow up
visit. Patients treated with RFA showed this pronounced finding (n=13,
48.1%) compared to only 25% (n=3) in those treated with EVLA.
The other major complication was the wound infection which
occurred at the groin in 4patients (8.69%) treated with HL/S and at the
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cut down site in 1 patient (3.7%) treated with RFA. The same was
treated with parenteral antibiotics, analgesics and local wound care.
Another related problem regarding groin dissection was lymphocele
which was observed in 5 patients (10.8%) in HL/S group. Lymphocele
were small measuring 5 to 10cc as measured while duplex examination,
which were managed conservatively.
Skin burns were observed in 4 (14.8%) patients in the RFA group and
non in the EVLA group. Burns were superficial with minimal
surrounding erythema. All were managed conservatively.
Bruising was observed in 17 (36.95%) patients who underwent
HL/S and in one patient (3.7%) in RFA treatment group (P
Value=0.0005). The bruising resolved in 3 weeks time and was not
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observed in most of the patients during the first follow up visit at one
month.
Numbness and parasthesia along the distribution of saphenous
nerve was seen in 9 (19.56%) patients who underwent HL/S and in one
(3.7%) patient who underwent RFA. The paresthesia resolved in 3
months time in RFA treated patient whereas parasthesia was persistent
until 6 months in the HL/S patients.
Deep venous thrombosis was observed on the second post operative
day in one patient who underwent EVLA. The incidence of DVT in this
study was 2.56% (P Value=0.04). In the rest of the patients who
underwent endovenous ablation there was no extension of thrombus
proximal to the superficial epigastric vein or the occurrence of DVT as
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observed by duplex examination within first 72 hours. The one
symptomatic patient was continued hospitalization for 2 weeks and
managed with parenteral anticoagulation, analgesics and limb
elevation. The patient was subsequently swapped to oral
anticoagulation and followed up on outpatient basis. The occurrence of
DVT in this patient was extension of the thrombus into the femoral
vein beyond SFJ. This finding is not infrequent after EVLA of GSV as
has been reported in the J Vasc Surg 2005;41:130-5 (Extension of
saphenous thrombus into the femoral vein: a potential complication of
new endovenous ablation techniques).
The average duration of hospital stay was also evaluated and also
compared. It was observed that the average duration of hospital stay
was 7 days in the HL/S group and 2 days in endovenous group.
                                             DAYS
1 2 3 4 5 6 7 8 9 10 11 12 13 14
HL/S   3  40 1  2
RFA  20 3  1  2 1
EVLA 3 4 4  1
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The outcome or the procedural success was assessed by clinical
improvement in CEAP classification, including the rate of ulcer healing
and improvement in VCSS and by duplex examination.
Both treatment groups had 100% procedural success rate with
the extirpation of the varicosed segment of veins and obliteration of
refluxing segments of veins in HL/S and endovenous groups
respectively with disappearance of clinically visible veins.
The Venous Clinical Severity scores improved significantly from
a mean of 5.4 (range, 1 to 16) and 3.1 (range, 1 to 12) to 0.84 (range, 0
41
to 4) and 0.435 (range, 0 to 4) at the third visit (6 month) follow up in
the HL/S and endovenous group respectively.
TABLE 7: OUTCOME ANALYSIS
Measures Pretreatment 72
hrs
1 month 6 month 1
yrs
VCSS HL/S 4.9     -       - 0.8     -
ENDO 3.1     -       - 0.4     -
Group Statistics at 6 month
Group N Mean Std. Dev P-Value
VCSS
HL/S 46 0.91 0.839
0.005
ENDO 39 0.41 0.751
Student – t (Independent samples) Test is applied to calculate the P-
Value
The mean ulcer size was 4cm (n=1) in HL/S, 3cm (n=3) in RFA
and 2.33cm (n=3) in EVLA group with rate of ulcer healing of 75%,
83.33% and 82.84% respectively at the end of 1 month and 100% in all
groups at the end of 6 months.
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TABLE 8: OUTCOME ANALYSIS
Measures Pretreatment 72 hrs 1 month 6 month 1 yrs
ULCER
SIZE
HL/S
4cm 4cm 1cm 0     -
RFA 3cm 3cm 0.5cm 0     -
EVLA 2.33cm 2.33cm 0.833 0     -
Statistics
Ulcer size
RFA
N 3
Mean 0.6667
Median 0.5000
Std. Deviation 0.28868
EVLA
N 3
Mean 0.8333
Median 1.0000
Std. Deviation 0.28868
P-Value for ulcer size at 1 month between RFA and EVLA P= 0.700
Mann – Whitney U-Test is applied to calculate the P-Value.
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The ultrasound follow up in the post operative period was used
to compare the results for length of GSV occlusion, residual patent
segments and reflux findings and also the status of deep veins. Absence
of GSV and reflux at SFJ was noted in all the treated limbs in HL/S
group (100%, n=46). The treatment success was defined as closed great
saphenous vein with lack of flow i.e. less than 5cm of proximal patent
vein and no reflux in the patent segment in the endovenous group. All
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the patients in the endovenous group (100%, n=39) fitted into the
technical success criteria and remained closed till the end of follow up
at the end of one year.
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TABLE 9: OUTCOME ANALYSIS
Measures Pretreatment 72 hrs 1 month 6 month 1 yrs
CEAP HL/S C2 to C6 Co Co Co Co
ENDO C2 to C6 Co Co Co Co
VCSS HL/S 5.4     -       - 0.84     -
ENDO 3.1     -       - 0.435     -
ULCE
R SIZE
HL/S
4cm 4cm 1cm 0     -
RFA 3cm 3cm 0.5cm 0     -
EVLA 2.33cm 2.33 0.433 0     -
GSV
STAT
US
HL/S Varicose
veins
absent absent absent Absent
ENDO Varicose
veins
closed closed Closed Closed
DISCUSSION
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DISCUSSION
The conventional treatment for the patients with symptomatic
incompetent superficial veins is best done by removing the refluxing
saphenous vein from the saphenofemoral junction to a level at the knee
or up to the leg, with individual ligation of the named saphenous
branches at the groin.
High ligation(Trendelenberg) and stripping is considered to be
the standard treatment of varicose veins, as it has highest rate of initial
rate of success and lowest rate of recurrence.22,23 Any other alternative
techniques to high ligation and stripping of saphenous vein should have
the same or a better outcome, without any associated morbidity. The
newer techniques are minimally invasive endovascular obliteration of
the vein with the radiofrequency or laser generated heating probes
placed inside the vein through the percutaneous puncture or by cut
down in the upper leg.
The aim of our study was to compare the efficacy of the
treatment with endovenous technique with the standard open technique
(high ligation and stripping) for abolishing superficial venous
incompetence and thereby bringing about symptomatic relief.
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The study was designed as prospective study with the assessment
of operative adverse events and post operative sequelae and recovery of
the patient for a short term of one year.
In this study, 85 patients were enrolled out of which 74 were
males and 11 were females. Though the female incidence with varicose
vein is higher in general population, the poor participation of females in
our study arm could probably be that they preferred a trial compression
therapy during the period of enrollment.
46(54%) patients underwent high ligation and stripping and
39(46%) patients underwent endovenous obliteration by means of
radiofrequency ablation [27(32%)] and laser ablation [12(14%)]. The
study sample was well matched with the other randomized
studies.8,12,13,21  The mean age of  incidence was 40±5 years  in  females
and 50±5years in males.8,21
Clinical classification of the varicose veins were done based on
CEAP classification and among those who underwent treatment
78%(n=66) belonged to C2, 6%(n=5) belonged to C2,4a , 8%(n=7)
belonged to C2,5 and 8%(n=7) belonged to C2,6.
In this study, HL/S and endovenous thermal ablation were found
to be equally efficient in eliminating the incompetent saphenous vein as
48
demonstrated by duplex examination within 72 hours of procedure with
the success rate of 100%. The similar success rate have been shown in
various studies; randomized trial comparing endovenous laser ablation
of GSV with HL/S in patients with varicose veins: short term results
from the American Venous Forum(100%)21, J Vasc Surg.2009: In a
meta analysis a success rate of 93.3% for EVLA, 87.5% for RFA and
80.4% for HL/S19, J of cardiovascular surgery 2005(96 to 100%) was
observed. The mean follow up period in above literature quoted were
between 6 months to 3 years.
The occurrence of adverse events was minimum and not
different among the groups. Apart from bruising, which was
statistically more (P Value=0.0005, <0.05) in the HL/S group (39.95%)
compared to RFA (3.7%) and none in EVLA, the bruising event was
low in our study compared to other studies which showed 52% in HL/S
and 27% in RFA (J Vasc Surg 2003) and 25% and 11% in HL/S and
EVLA respectively (J Vasc Surg 2007).
 4 patients in HL/S (8.69%) and 1 patient in RFA (3.7%)
underwent treatment for infection at groin and cut down site
respectively. Such infection rate was low compared with another study,
where infection was reported in 13.7% of patients after high ligation of
saphenous vein (J R Coll Surg Edinb 1991). The occurrence of
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lymphocele was high (10.86%) in our study compared to other study
(2.8%)(J Vasc Surg 2003) in the HL/S group.
 In our study the incidence of parasthesia was higher in HL/S
group (19.56%) compared to RFA (3.7%) and EVLA (8.3%) where as
the other study from literature showed higher incidence in RFA
(23.3%) and EVLA (2%) compared to HL/S (13.9%)8,21. Similar
incidence of parasthesia in HL/S (15%), RFA (3.8%) and EVLA
(7.8%)7 was observed in another study.
Burns as a procedural complication occurred in 4 (14.8%)
patients in RFA group and none (0%) in EVLA group. Skin burns have
been reported in the literature using the 1064nm Nd:YAG laser (Lasers
Surg Med 2002) and none with the diode Lasers (early results of
various laser ablation studies)2. The incidence of skin burns has been
reported as 2-4% in the results of various RFA studies2.
Although DVT has been reported in up to 5.6% of laser patients
and up to 16% in RFA patients1,2,7 , our study had one incidence of
DVT (8.3%) in EVLA group which was managed successfully with
anticoagulation.
Post operative pain in the leg was higher after HL/S compared
with endovenous procedures as indicated by  statistically significant
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differences in pain score as well as by the presence of tenderness
(P<0.0001) in all 46 patients who underwent HL/S. The pain was
usually located to the thigh. However a paired study comparing EVLA
(810nm laser) and HL/S performed with regional anesthesia found no
difference in pain between the groups, but the patients indicated more
benefit in the leg treated with laser in addition to less bruising and
edema (Dermatol Surg 2005). The tumescent fluid placed within the
saphenous canal under ultra sound guidance may have probably
reduced the immediate post operative pain in the endovenous group as
there was no significant difference in pain score in the subsequent
follow up visits in both the groups.
 Similarly the rate of ulcer healing was observed to be slightly
better in the endovenous group with healing rate of 83.33% and
82.84% for RFA and EVLA at the end of one month and 75% in the
HL/S group, though they are not statistically significant (P=0.700,
>0.05). The rate of ulcer healing was not separately observed in most
of the randomized studies as this parameter was included as one of the
component of the VCSS. As expected, the VCSS improved similarly in
both the groups. The mean scores improved significantly (P<0.05) after
operation, falling from a mean of 5.4 (range 1to16) and 3.1 (range
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1to12) to 0.84 (range 0 to 7) and 0.435 (range 0 to 4) at 6 months in the
HL/S and endovenous group respectively.
Also the average duration of hospital stay was considerably less
in the endovenous group averaging 2 days compared to 7 days in the
HL/S group with return to normal activities in less than 2 days in
endovenous group and averaging 5 days in HL/S group. The same was
observed in other studies where the return to normal activities were 3.5
(0-8) in EVLA and 14 (3-28) days in HL/S groups7 and 0 to 3 days in
RFA Vs 3 to 15 days in HL/S group8.
The last decade has seen the evolution of new minimally
invasive methods including radiofrequency ablation, endovenous laser
ablation and foam sclerotherapy for the treatment of GSV
incompetency as an alternative to conventional high ligation and
stripping. There are several randomized controlled trials involving
these new methods that are available in the literature. A few of them
are quoted here for application of interpretation of the study conducted
here :
1) In one randomized controlled trial which compared laser
ablation with open surgery, there were no difference in
pain scores, but a significantly less bruising and swelling
occurred following EVL ablation25.
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2) There are five RCTs which compare RFA with EVLA.
The trials showed similar complication and closure rate
in both groups13. Kabnick concluded that the most
current RFA and jacket tipped EVLA methods and
devices are indistinguishable in terms of efficacy and
short term results. These procedures present no
significant differences from the patient’s point of view as
the procedure time and use of tumescent anesthesia was
same.
3) The four RCTs comparing radio frequency ablation with
high ligation and stripping demonstrated that radio
frequency ablation have significant advantages, that
included faster recovery, less operative pain, fewer
adverse events and improved quality of life scores8,9,26,27
when compared to conventional stripping.
4) One RCT compared open surgery Vs EVLA Vs RFA Vs
ultrasound guided foam sclera therapy (UGFS)13. The
study observed better quality of life (SF36), and also
lower pain score (P<0.001) and shorter time away from
work (P<0.001) in RFA and UGFS groups. Also GSV
occlusion was better with HL/S, RFA and EVLA than
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with  UGFS  (P  less  than  0.0001).  There  was  no
significant difference in clinical recurrence in all the
treatment groups.
 The May 2011 issue of JVS published the final
conclusions of Society for Vascular Surgery/ American
Venous Forum guidelines for treatment of varicose veins.
Owing to the minimally invasive nature as well as similar
or better early term and equivalent midterm results,
endovenous thermal ablation is to be recommended as
the first line of treatment of varicose veins associated
with axial reflux over open surgery 13.
HL/S RFA EVLA P HL/S EVLA P HL/S RFO P HL/S EVA P
1 Study Sample
n=46 n=27 n=12 - 59 62 - 36 40 - -  - -
3
Procedures
Success Rate
 100%  100%  100% - 97% 96% - 100%  95%  - 95 – 99% 92 – 98%  -
4 Bruesing  36.95% 4% - <0.05 25% 11% - 52% 27% - - - -
5 Burns - 14.80% - >0.05 - - - - - - - 2 – 4 % -
6 Paraesthesia
 19.56% 3.70% 8.30% >0.05  8% 2% - 5.60% 11.40% - 15% 3.80% 7.80%
7
Wound
Infection  8.69  3.7% -  >0.05 2% - - 5.60% - - 13.70% - -
8 DVT  - - 8.30% >0.05  - - - - - - - 5.6-16% -
9
Pain /
Tenderness  100% - - <0.05 24% 3.70% <0.05 25% 4.50% <0.01 - - -
10
Rate of
wound
healing
 75% 82% 83% 0.7
Not
reported
Not
reported
Not
reported
Not
reported
Not
reported
Not
reported
Not
reported
Not
reported
Not
reported
11 VCSS 0.8 0.35 0.5 <0.05 0.2 0.4 - 0.7 0.6 <0.03 - - -
12
Hospital Stay
/ Return to
Normal
Activities
7 days 3 days 2 days <0.05 14 days 3.5 days <0.05 12.4 days 4.7 days <0.05 15 days 3 days <0.05
Other Studies
Srl No
Our Study AVF-EVLA Vs HL/S EVOL VeS
Table : 10; Comparison of parameters among various studies:-
 6 months
to 3 years
 -4 months 4 months -
6 months
to 3 years
2
Follow-up
Period
 1 year 1 year 1 year  - 6 month 6 months -
CONCLUSION
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 CONCLUSION
1) This study shows that the short term efficacy and safety of
endovenous ablation and open surgery are similar in the
treatment of varicose veins.
2) Endovenous ablation presents with lesser post operative
morbidity in terms of post operative pain, bruising and
hospital stay which was significantly higher in HL/S
group.
3) Both the treatments are equally safe and efficient in
eliminating great saphenous vein reflux, thereby
alleviating symptoms and signs of GSV varicosities and
improving quality of life.
4) Symptom reduction and cosmetic improvement after
endovenous procedures are slightly better when compared
to surgery.
5) Endovenous procedures can be done as a day care
procedure which allows a rapid return to normal activity
and also earlier return to work.
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6) Endovenous procedures has lower complication rates than
surgery, particularly in respect of saphenous parasthesia
wound problems, hematoma formation and bruising.
7) Although it might appear that EVLA has some advantages
over RFA in terms of frequency of complications like
bruising, skin burns and “cord like pulling sensation”,
there is no clear evidence that one or the other should be
the preferred procedure.
8) Given the choice, most patients will choose endovenous
procedures instead of an operation with a cut in the groin
and vein stripping.
9) This will become particularly true if the long term
outcomes, including the recurrence rates, remain equal.
10) Considering the ease and comfort of the procedure,
with fewer peri procedural complications and equivalent
short and midterm results the endovenous procedure
definitely has an edge over the traditional open procedure .
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MASTER CHART
A B C D A B C D A B C D A B C D A B C D
1 Kadarkarai 42 M 45322 R C2 EVLT      -            -      - 3    -   -   -   - C? ?? ?? ?? X X X X    -   -   -   -   -    -   -   -
2 Mani 36 M 45623 R C2 Trendelenburg   yes            -      - 7 yes yes   -   - C? ?? ?? ??    -   -  -   -    -  -   -   -   -   -   -  -
3 Udhayasankar 35 M 3786 R C2 Trendelenburg     -            -      - 7 yes    -   -   - C? C? C? C?    -   -   -   -   -   -   -   -   -   -   -   -
4 Baskar 29 M 4075 L C2C4? Trendelenburg   yes            -      - 7 yes    -   -   - C?C4? C?C4? C?C4? C?C4?    -   -   -   -   -   -   -   -   -   -   -   -
5 Anandh 33 M 4670 L C2C6(4cm) EVLT      -            -      - 3    -   -   -   - C?C6 C?C6 ??C5 C?C5 X X X X 4cm 2cm   -   -   -   -   -   -
6 Mani 63 M 3197 L C2C6(2cm) EVLT      -            -      - 3    -   -   -   - C?C6 C?C6CC?C5 ??C5 X X X X 2cm 1cm   -   -   -   -   -   -
7 Malaiyatri 50 M 6513 L C2 Trendelenburg   yes        yes      - 10 yes yes    -   - C? C? C? C?    -   -   -   -   -   -   -   -   -   -   -   -
8 Selvaraj 33 M 3524 L C2 Trendelenburg   yes            -      - 7 yes    -   -   - C? C? C? C?    -   -   -   -   -   -   -   -   -   -   -   -
9 Mhd.Habeeb 33 M 6035 R C2 EVLT      -            -      - 2    -   -   -   - C? C? C? C? X X X X    -   -   -   -   -   -   -   -
10 Ganesh Kumar 35 M 9669 R C2 EVLT      -            -      - 2    -   -   -   - C? C? C? C? X X X X    -   -   -   -   -   -   -   -
11 Sheriff 40 M 230/12 L C2 RFA      -            -      - 3 yes    -   -   - C? C? C? C? X X X X    -   -   -   -   -   -   -   -
12 Britto 36 M 9757 L C2C4? Trendelenburg     -            -      - 7 yes    -   -   - C?C4? C?C4? C?C4? C?C4?    -   -   -   -   -   -   -   -   -   -   -   -
13 Anandraj 55 M 124/12 R C2C4? RFA      -            -      - 3    -   -   -   - C?C4? C?C4? C?C4? C?C4? X X X X    -   -   -   -   -   -   -   -
14 Purushotaman 54 M 15865 L C2 EVLT      -            -      - 2    -   -   -   - C? C? C? C? X X X X    -   -   -   -   -   -   -   -
15 Elangovan 30 M 822/08 L C2 RFA      -            -      - 2 yes    -   -   - C? C? C? C? X X X X    -   -   -   -   -   -   -   -
16 Soundararaj 32 M 16682 L C2 Trendelenburg   yes        yes      - 7 yes    -   -   - C? C? C? C?    -   -   -   -   -   -   -   -   -   -   -   -
17 Karunanidhi 36 M 16504 L C2 RFA      -            -      - 2    -   -   -   - C? C? C? C? X X X X    -   -   -   -   -   -   -   -
18 Chandrasekar 55 M 16895 L C2 RFA      -            -      - 2    -   -   -   - C? C? C? C? X X X X    -   -   -   -   -   -   -   -
19 Senthil kumar 26 M 17888 R C2 EVLT      -            -      - 1    -   -   -   - C? C? C? C? X X X X    -   -   -   -   -   -   -   -
20 Muthukrishnan 30 M 17883 L C2 Trendelenburg     -            -      - 7 yes    -   -   - C? ?? ?? ??    -   -   -   -   -   -   -   -   -   -   -   -
21 Muthuraj 42 M 9522 L C2 EVLT      -            -      - 2    -   -   -   - C? C? C? C? X X X X    -   -   -   -   -   -   -   -
22 Ravi 25 M 15811 L C2 Trendelenburg     -        yes      - 7 yes    -   -   - C? C? C? C?    -   -   -   -   -   -   -   -   -   -   -   -
23 Rathina sekar 22 M 14572 L C2 Trendelenburg     -            -      - 7 yes    -   -   - C? C? C? C?    -   -   -   -   -   -   -   -   -   -   -   -
24 Ravichandran 45 M 21121 R C2C4? Trendelenburg     -            -      - 7 yes    -   -   - C? C? C? C?    -   -   -   -   -   -   -   -   -   -   -   -
LIMB CEAP
Hospital
 stay in
daysbruising
Peri-OP Events
saphenous
paraesthesia
burns
Procedure
Follow-up
Pain CEAP GSV Status Ulcer Size DVTIP nosexageNamesl no
25 Saiadammal 41 F 20418 R C2 RFA      -            - yes 7 yes    -   -   - C? C? C? C?    -   -   -   -   -   -   -   -   -   -   -   -
26 Ramesh 48 M 14812 R C2 RFA      -            -      - 2    -   -   -   - C? C? C? C? X X X X    -   -   -   -   -   -   -   -
27 Britto 21 M 18512 L C2 Trendelenburg     -            -      - 7 yes    -   -   - C? C? C? C?    -   -   -   -   -   -   -   -   -   -   -   -
28 Pandurangan 48 M 22604 R C2C4? Trendelenburg     -            -      - 7 yes    -   -   - C? C? C? C?    -   -   -   -   -   -   -   -   -   -   -   -
29 Senthamarai 48 M 16324 L C2 RFA      -            -      - 5 yes    -    -    - C? C? C? C?    -    -    -    -    -    -    -    -    -    -    -    -
30 Muthukumar 35 M 191/12 L C2 Trendelenburg    yes            -      - 7 yes    -    -    - C? C? C? C?    -    -    -    -    -    -    -    -    -    -    -    -
PROFORMA
PROFORMA
Case No:
Name:                                                                             Age:        Yrs        Sex:
I.P.No:
Occupation:
Address:
Contact No:
Date of Admission:
Date of Surgery:
Date of Discharge:
Presenting History: (Venous Clinical Severity Scoring)
Duration Onset None-
0
Mild-
1
Moderate-
2
Severe-
3
Pain
Varicose
veins
Edema legs
Skin
pigmentation
Inflammation
Induration
Ulcer
Past History:
Yes No
H/O trauma
H/O previous surgery
H/O prolong
immobilization
H/O previouo DVT
H/O DM/HT/PTB
H/O drug intake
Family History of Varicose Veins:     Y/N
Treatment History:
Conservative Modality Tried:     Y/N
Smoker:       Y/N
General examination:
BMI- CVS:
PR-    RS:
BP-  P/A:
Local Examination:
Limb involved:     Right/Left
CEAP:
Ulcer: Size –
Site –
Edge –
Floor –
Peripheral pulses:
ABI:
INVESTIGATIONS:
Hb%
TC
DC
ESR
Blood- urea
Blood-sugar
Sr.Creatinine
CXR
ECG
DUPLEX SCAN:
SFJ reflux -   Y/N   - time
SPJ reflux -   Y/N   - time
Perforators -   Sites                         Reflux  -  Y/N
GSV  diameter at   -   SFJ Mid thigh Below
Knee
GSV  anamolies      -
Deep vein status    -
TREATMENT:
EVENTS SURGERY RFA(VNUS
CLOSURE FAST)
EVLT(1470nm
LASER)
1 Anaesthesia
2 Procedure  High Ligation and
Stripping(Trendelenburg)
Port of entry: Port of entry:
GSV length
ablated:
GSV length
ablated:
RF cycles: Pull back
speed:
Total
treatment
time:
Total
treatment
time:
Treatment
time:
Treatment
time:
Treatment
power:
Treatment
power:
3 Peri
operative
events:
a)Bruising
b)saphenous
parasthesia
c)skin burns
4 Hospital
stay in days
FOLLOW UP:
Immediate
Post OP(72
hrs)
2weeks-
1month
4-6 months 10-12
months
Pain
CEAP
Ulcer size
GSV status
DVT

